Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis, Chemical Characterization, and μ-Opioid Receptor Activity Assessment of the Emerging Group of “Nitazene” 2-Benzylbenzimidazole Synthetic Opioids
Marthe M. Vandeputte, Katleen Van Uytfanghe, Nathan K. Layle, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 7, pp. 1241-1251
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl
Laura C. Chambers, Benjamin D. Hallowell, Andrew R. Zullo, et al.
JAMA Network Open (2023) Vol. 6, Iss. 9, pp. e2334540-e2334540
Open Access | Times Cited: 55
Clinical toxicity of nitazene detections in two Australian emergency department toxicosurveillance systems
Katherine Isoardi, Sam Alfred, Courtney Weber, et al.
Drug and Alcohol Review (2025)
Open Access | Times Cited: 6
Naloxone Dosing and Hospitalization for Nitazene Overdose: A Scoping Review
J. Berger, Alec D. Severe, Mohamed A. Jalloh, et al.
Journal of Medical Toxicology (2025)
Closed Access | Times Cited: 4
DARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles
István Ujváry, Rachel Christie, Michael Evans‐Brown, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 7, pp. 1072-1092
Closed Access | Times Cited: 88
Treatment of overdose in the synthetic opioid era
Phil Skolnick
Pharmacology & Therapeutics (2021) Vol. 233, pp. 108019-108019
Open Access | Times Cited: 85
Review- biological active benzimidazole derivatives
Balasaheb Pathare, Tanaji N. Bansode
Results in Chemistry (2021) Vol. 3, pp. 100200-100200
Open Access | Times Cited: 79
The Rise and Fall of Isotonitazene and Brorphine: Two Recent Stars in the Synthetic Opioid Firmament
Marthe M. Vandeputte, Alex J. Krotulski, Donna M Papsun, et al.
Journal of Analytical Toxicology (2021) Vol. 46, Iss. 2, pp. 115-121
Open Access | Times Cited: 57
Acute Intoxications and Fatalities Associated With Benzimidazole Opioid (Nitazene Analog) Use: A Systematic Review
Eva Montanari, Graziella Madeo, Simona Pichini, et al.
Therapeutic Drug Monitoring (2022) Vol. 44, Iss. 4, pp. 494-510
Closed Access | Times Cited: 54
Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole ‘nitazene’ synthetic opioid
Marthe M. Vandeputte, Alex J. Krotulski, Donna Walther, et al.
Archives of Toxicology (2022) Vol. 96, Iss. 6, pp. 1845-1863
Open Access | Times Cited: 50
Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017–2020: A Review
Amanda L A Mohr, Barry K. Logan, Melissa F. Fogarty, et al.
Journal of Analytical Toxicology (2022) Vol. 46, Iss. 6, pp. e116-e185
Open Access | Times Cited: 46
Intoxications in an Australian Emergency Department Involving ‘Nitazene’ Benzylbenzimidazole Synthetic Opioids (Etodesnitazene, Butonitazene and Protonitazene)
Jennifer Schumann, Rebekka Syrjanen, Katherine Alford, et al.
Journal of Analytical Toxicology (2022) Vol. 47, Iss. 1, pp. e6-e9
Closed Access | Times Cited: 39
Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients
Alexandra Amaducci, Kim Aldy, Sharan Campleman, et al.
JAMA Network Open (2023) Vol. 6, Iss. 8, pp. e2331264-e2331264
Open Access | Times Cited: 36
Old Drugs and New Challenges: A Narrative Review of Nitazenes
Joseph V. Pergolizzi, Robert B. Raffa, Jo Ann LeQuang, et al.
Cureus (2023)
Open Access | Times Cited: 30
New Psychoactive Substances Intoxications and Fatalities during the COVID-19 Epidemic
Alfredo Fabrizio Lo Faro, Diletta Berardinelli, Tommaso Cassano, et al.
Biology (2023) Vol. 12, Iss. 2, pp. 273-273
Open Access | Times Cited: 23
Mu-opioid receptor selective superagonists produce prolonged respiratory depression
Nicholas J. Malcolm, Barbara Palković, Daniel J. Sprague, et al.
iScience (2023) Vol. 26, Iss. 7, pp. 107121-107121
Open Access | Times Cited: 23
Pharmacologic Characterization of Substituted Nitazenes atμ,κ, andΔOpioid Receptors Suggests High Potential for Toxicity
Laura B. Kozell, Amy J. Eshleman, Katherine M. Wolfrum, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 389, Iss. 2, pp. 219-228
Open Access | Times Cited: 13
Human metabolism of four synthetic benzimidazole opioids: isotonitazene, metonitazene, etodesnitazene, and metodesnitazene
Omayema Taoussi, Diletta Berardinelli, Simona Zaami, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 7, pp. 2101-2116
Open Access | Times Cited: 13
In vitro, in vivo metabolism and quantification of the novel synthetic opioid N-piperidinyl etonitazene (etonitazepipne)
Diletta Berardinelli, Omayema Taoussi, Jérémy Carlier, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2024) Vol. 62, Iss. 8, pp. 1580-1590
Closed Access | Times Cited: 10
In vitro structure–activity relationships and forensic case series of emerging 2-benzylbenzimidazole ‘nitazene’ opioids
Liam M. De Vrieze, Sara E. Walton, Eline Pottie, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 9, pp. 2999-3018
Open Access | Times Cited: 10
In Vitro Functional Profiling of Fentanyl and Nitazene Analogs at the μ-Opioid Receptor Reveals High Efficacy for Gi Protein Signaling
Meng-Hua M. Tsai, Li Chen, Michael H. Baumann, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 4, pp. 854-867
Closed Access | Times Cited: 9
Wastewater-based monitoring of the nitazene analogues: First detection of protonitazene in wastewater
Richard Bade, Dhayaalini Nadarajan, Erin M. Driver, et al.
The Science of The Total Environment (2024) Vol. 920, pp. 170781-170781
Open Access | Times Cited: 9
Evaluation of rewarding effects of nitazene analogs: results from conditioned place preference tests and <i>in vivo</i> microdialysis experiments in mice
Kyoko Hataoka, Motoki Hojo, Sakiko Nomura, et al.
The Journal of Toxicological Sciences (2025) Vol. 50, Iss. 1, pp. 33-43
Open Access | Times Cited: 1
LCMS Detection and Characterization of In Vitro Metabolites of Isotonitazene, a Targeted Strategy for Novel Psychoactive Substance Control in Camel Racing
Jahfar Nalakath, Rasik Puzhithinipra Rasik, Ahmed Kadry, et al.
Rapid Communications in Mass Spectrometry (2025) Vol. 39, Iss. 7
Closed Access | Times Cited: 1
UHPLC-MS/MS-based Analysis of 17 Nitazenes in Human Hair for Practical Forensic Casework with Simultaneous Separation of 6 Groups of Isomers
Guoqing Gao, Shuo Yang, Xin Wang, et al.
Journal of Pharmaceutical and Biomedical Analysis (2025) Vol. 257, pp. 116707-116707
Closed Access | Times Cited: 1
The UHPLC-MS/MS method for the determination of 26 synthetic benzimidazole opioids (nitazene analogs) with isomers separation
Olga Wachełko, Kaja Tusiewicz, Paweł Szpot, et al.
Journal of Pharmaceutical and Biomedical Analysis (2025) Vol. 260, pp. 116796-116796
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top